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Membrane proteins induce the required communication between the cell and the surround-
ing environment, therefore they can act as transporter proteins. They can be used by differ-
ent pathogens, such as bacteriophages, among which we find T5, in the process of an in-
fection. Through its RBP, it has the ability to infect E. coli with great specificity, using one of 
the bacteria’s transporters to recognize and bind to the cell. 
In this study, the proteins FhuA and pb5 were targeted with the purpose of characterizing a 
membrane protein complex, formed by a) the bacterial ferrichrome transporter ‘FhuA’, pre-
sent in E. coli bacterial outer membrane and b) the bacteriophage T5’s viral tail tip protein 
‘pb5’. VHH antibodies were also used in order to optimize the crystallization between FhuA 
and pb5 by increasing the soluble surface of the complex. A process of overexpression in 
E. coli cells and later purification using different chromatographic methods were performed, 
followed by crystallization, either by hand in the laboratory or in an HTX platform. 
As a result, various steps of the different methods were improved, extra information on the 
handling of the different proteins was provided and several crystals were obtained success-
fully. These crystals will be used for X-ray crystallography and if they possess the expected 
quality, the FhuA-pb5 complex’s 3D structure could be obtained. Further studies are still 
needed to solve this structure, in order to enlighten the phage T5’s infection process and 
interaction with the transporter. 
The project was carried out in Grenoble, France, in the Institut Biologie Structurale (IBS) 
research center in the group of Membranes and Pathogens (M&P). 
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Membraaniproteiinit mahdollistavat tarvittavan viestinnän solun ja sen ympäristön välillä, 
jonka vuoksi ne voivat toimia muun muassa kuljettajaproteiineina. Niitä voi kuitenkin käyt-
tää hyväkseen myös erilaiset patogeenit infektioprosesseissaan, kuten bakteriofaagit, 
joista eräänä myös T5.Se käyttää reseptoriin sitoutuvaa spesifistä proteiiniaan E.colin in-
fektoimiseen, käyttäen bakteerin kuljettajaproteiinia solun kiinnittymiseen ja tunnistami-
seen. 
Kyseisessä tutkimuksessa keskityttiin kahteen proteiiniin, tarkoituksena proteiinikomplek-
sin tutkiminen, muodostuen a) E. colin ferrikromikuljettajaproteiini “FhuA:sta”, esiintyen 
bakteerin solukalvolla ja b) bakteriofaagin häntäproteiinin ”pb5:stä”: Myös VHH antibodeja 
käytettiin FhuA:n ja pb5:n kristallisoimisen optimoimiseksi, joiden tarkoituksena oli lisätä 
kompleksin liukoisuutta. Tekniikkoina käytettiin ekspressiota E.coli -soluissa ja erilaisia kro-
matografisia puhdistusmenetelmiä, jonka jälkeen kristallisaatio suoritettiin, joko käsin pipe-
toimalla, tai ulkoisen HTX laboratorion avulla. 
Tuloksena saavutettiin usean työvaiheen optimointi, lisäinformaation saavuttaminen prote-
iinien käsittelystä, sekä usean kristallin muodostuminen, joita voidaan jatkossa käyttää 
röntgensädekristallografiassa, jos niiden laatu täyttää vaatimukset. Tällöin voitaisiin saa-
vuttaa FhuA-pb5 proteiinikompleksin kolmiulotteinen rakenne, mikä avaisi faagin infek-
tioprosessia ja vuorovaikutusta kuljettajaproteiinin kanssa. 
Projekti suoritettiin Grenoblessa, Ranskassa, IBS -tutkimuskeskuksessa (Institut Biologie 
Structurale), tutkimusryhmässä nimeltä Membraanit ja Patogeenit (M&P). 
Avainsanat Bakteriofaagit, Membraaniproteiinit, Proteiinikompleksi, Kris-
tallisaatio 
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Abbreviations  
AW740  Escherichia coli strain lacking OmpF and OmpC  
BL21 (DE3)  Derivative of BL21 E coli strain with T7 RNA polymerase gene 
CLAPA  Chymostatin Leupeptin Antipain Pepstatin and aprotinin 
CMC  Critical Micelle Concentration 
DNase  Deoxyribonuclease 
dsDNA  Double-Stranded Deoxyribonucleic Acid 
E. coli  Escherichia coli 
EDTA  Ethylenediaminetetraacetic acid 
EM  Electron Microscopy 
EMBL  European Molecular Biology Laboratory 
FhuA  Ferric Hydroxamate Uptake A 
GE  General Electric  
HTX  High Throughput Crystallization 
IBS  Institut de Biologie Structurale (Structural Biology Institute) 
IPTG  Isopropyl β-D-1-Thiogalactopyranoside 
LB  Lysogeny Broth 
LDAO  Lauryldimethylamine Oxide 
LPS  Lipopolysaccharide  
M&P  Membrane and Pathogens 
MES  2-(N-morpholino) Ethanesulfonic Acid 
NiNTA  Nickel-nitrilotriacetic acid 
NMR  Nuclear Magnetic Resonance 
OPOE  Octyl-polyoxyethylene 
PAGE  Polyacrylamide gel electrophoresis 
pb5  Protein Binding 5 
Phage  Bacteriophage 
Psi  pounds per square inch 
PTM  Post-Translational Modification 
Q HP  Q Sepharose High Performance 
RBP  Receptor Binding Protein 
SDS-PAGE  Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis 
SEC  Size Exclusion Chromatography 
SP HP   SP Sepharose High Performance 
ssDNA  Single-Stranded Deoxyribonucleic Acid 
ssRNA  Single-Stranded Ribonucleic Acid 
dsRNA  Double-Stranded Ribonucleic Acid 
T1  Type 1 
T5  Type 5 
TB  Terrific Broth 
Tris  Tris(hydroxymethyl)aminomethane 
UV/Vis  Ultraviolet-Visible Spectrophotometry 
VHH  Variable Domain of Heavy-Chain Antibody 
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1 Introduction 
In biology, proteins are the main actors within the cell, where they carry out duties spec-
ified by the information encoded in them genetically. Different proteins perform various 
functions depending on their physicochemical properties and location inside of the cell. 
The diversity in how they act relies on their ability to bind tightly to other specific mole-
cules, proteins and small-molecule substrates [1]. However, proteins can also bind or be 
integrated into cell membranes, known as membrane proteins. Their binding ability can 
induce conformational changes in proteins and allow, therefore, the construction of ex-
tremely complex signaling networks [2].  
 
Since the membrane surrounds biological cells, it is in charge of protecting its interior 
against an exterior hostile environment and, consequently, the proteins that reside in this 
membrane induce the required communication between the cell and the aforementioned 
environment. These membrane proteins can act as transporters, cell adhesion mole-
cules or even possess enzymatic activity, vital for the normal function of a cell [3]. Be-
cause of their presence in the membrane, these proteins have gained increased im-
portance in the field of infectiology, given that they can be used by different pathogens 
(viruses, bacteria and/or toxins) in the process of an infection. Knowledge of these pro-
teins is essential to understand the functioning of the cell and the pathogenic proteins 
with which they interact [1]. 
 
Pathogens capable of infecting bacteria are bacteriophages, bacterial viruses. They pos-
sess a receptor binding protein (RBP) located in the tip of the tail in the case of T5, a 
tailed phage from the Caudovirales family [4]. This RBP gives the bacteriophage the 
ability to infect E. coli with great specificity, using one of the bacteria’s transporters to 
recognize and bind to the cell. 
 
The purpose of this project is to study, characterize and crystallize a membrane protein 
complex, formed by a) the bacterial ferrichrome transporter ‘FhuA’, present in E. coli 
bacterial outer membrane and b) the bacteriophage T5’s viral tail tip protein ‘pb5’. 
In vivo, this interaction triggers the infection of the bacteria by the phage, releasing the 
phage’s DNA into the bacterial cell. This complex is an excellent model to study this 
interaction because at the moment it is the only biochemically available outer membrane 
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complex with RBP [5]. The interest in this complex relies on the possibility of having 
different applications, with the use of phages for example in therapy.  
.  
Additionally, to optimize the crystallization between FhuA and pb5, it is possible to use a 
third protein, VHH lama antibodies, to increase the soluble surface of the complex. These 
lama antibodies are small proteins raised to bind to pb5, which otherwise aggregates 
easily alone. In this study, four different antibodies were used: VHH53, VHH54, VHH64 and 
VHH81.  
 
In structural biology, crystallization followed by X-ray crystallography is currently the most 
accurate way to obtain protein structures [6]. Therefore, FhuA-pb5 complex’s 3D struc-
ture could be obtained with this technique. Determining the structure of this membrane 
protein complex can be of great importance in understanding in detail how the first step 
of injection process occurs, enlightening the phage’s infection process and interaction 
with the transporter. 
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2 Theoretical Background  
2.1 Membrane Proteins 
Membrane proteins are cell components of great importance. They perform many of the 
functions that are vital for the survival of cells [7]. They can be bound or integrated into 
cell membranes. Binding of outside stimuli induces conformational changes in the pro-
teins allowing the construction of extremely complex signaling networks. Membrane pro-
teins reside in highly isolating lipid bilayers, surrounding biological cells, therefore pro-
tecting their interior against an external hostile environment. Consequently, these pro-
teins are in charge of the essential communication between the cell and the environment, 
catalyzing important reactions such as solute transport, charge separation, conversion 
of energy and signal transduction [3]. Membrane proteins can act as transporters, recep-
tors, cell adhesion molecules or even possess enzymatic activity, vital for the normal 
function of a cell.  
 
There are three major classes of membrane transport proteins: ATP-powered pumps, 
channel proteins and transporters (Figure 1). They exhibit a high degree of specificity for 
the transported substance. Due to differences in their mechanism of transport, the rate 
of action between them differs considerably [1].  
 
 
 
 
 
 
 
 
 
Figure 1. Graphic representation of the three classes of membrane transport proteins [1] 
2.1.1 Membrane Transporters 
Membrane proteins are capable of transporting a wide variety of ions and molecules 
across cellular membranes by binding to only one or a few substrate molecules at a time. 
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After this binding, they undergo a conformational change that impedes more binding to 
occur, therefore only these molecules are moved across the membrane [8]. 
Depending on their mode of action, non-ATPase transporters can be sub-classified in 
uniporters, symporters and antiporters, as shown in Figure 2. Uniporters transport one 
molecule at a time down a concentration gradient. Antiporters and symporters, how-
ever, are in charge of moving one type of ion or molecule against its concentration gra-
dient by coupling it with the movement of a different ion or molecule down its concentra-
tion gradient. As in the case of ATP-driven pumps, the latter two transporters mediate 
coupled reactions, in which a reaction that is energetically unfavorable is coupled to an 
energetically favorable one. Nonetheless, they do not hydrolyze ATP or any other mole-
cule. These proteins can be referred to as cotransporters, due to their ability to simulta-
neously transport two different solutes [1]. 
 
 
Figure 2. Different mechanisms used by membrane transporters, subclassified depending on 
whether they transport molecules with or against their concentration gradient [8]. 
 
Membrane proteins are present in all living organisms in large numbers, from mammalian 
to bacterial cells. Because of their presence in the membrane, these proteins have 
gained increased importance in the infectiology field, since different pathogens make use 
of them in the process of an infection, as it is the case of bacteriophages that infect 
bacterial cells.  
 
2.1.1.1 FhuA 
A transporter protein present in the outer membrane of E. coli is the transporter for ferri-
chrome-iron, named FhuA (Figure 3). Besides its physiological function to actively 
transport ferrichrome-iron into the cell, this membrane transporter has been high jacked 
by different pathogens and toxins; it is the primary receptor for the antibiotic albomycin 
as a consequence of its resemblance with the structure of its natural ligand for multiple 
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bacteriophages such as f80, T1, T5 and UC-1, for the bacterial toxin colicin M and lastly 
for the peptide antibiotic microcin 25 [9]. 
 
Figure 3.   FhuA is represented in a ribbon manner, oriented as it would be found in the outer 
membrane. The barrel is shown in blue, with a removal of the residues 621 to 723 in 
order to obtain an unobstructed view of the cork domain, an N-terminal globular do-
main that folds inside the barrel and occludes it, shown in yellow. Represented as ‘ball 
& stick’ models, the LPS and ferrichrome-iron molecules are seen, with a large red 
sphere indicating the iron atom. As for the dashed lines, they indicate the positions of 
the upper and lower aromatic girdles. The external pocket is seen as a space above 
the cork domain and the periplasmic pocket as a space below this domain. On the 
other hand, panel Figure 3B shows the view of FhuA from the external environment 
along the barrel axis. [7] 
2.1.2 Difficulties in the Study of Membrane Proteins 
It is challenging to determine membrane protein structures by any technique [10]. When 
studying membrane proteins, the main difficulty is obtaining the protein of interest. This 
is in part due to the low levels the membrane proteins usually present in biological mem-
branes. For this reason, their overexpression is necessary. However, a major problem 
encountered is the aggregation of the targeted protein in the cytoplasm due to the over-
crowding of the membrane-insertion machinery. Consequently, it is difficult to obtain a 
high yield of stable functional protein. Among the systems used for overexpression, E. 
coli is the most popular one due to its low cost and ease of use. However, mammalian 
proteins frequently require post-translational modifications (PTMs), which are unobtain-
able in bacterial hosts [11].  
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Furthermore, another difficulty is represented in the study of membrane proteins, be-
cause of their heterogeneous and complex environment; Membrane proteins are natu-
rally embedded in a lipid bilayer, indicating a large asymmetry and some lateral mobility 
within the membrane matrix, [12], making it more challenging to use the biophysical tech-
niques known to resolve protein structure and function, including NMR and X-ray crys-
tallography. These, among other techniques, result of restricted application, due to the 
requirement of an extraction of the protein from its native membrane and the study to be 
carried out in a detergent or lipid environment in vitro. Consequently, sample preparation 
and spectral contributions becomes difficult [11], representing a major challenge. Also, 
the insolubility in aqueous solutions of most of the membrane proteins [13] leads to a 
need to reside in environments that satisfy their high hydrophobicity, hence requiring 
special synthetic systems for an in vitro approach [11]. To help overcome this problem, 
innovative approaches have been recently developed, by redesigning membrane pro-
teins to obtain hydrophilic variants and adding solubilizing fusion proteins [13].  
 
2.1.2.1 Detergents  
 
Detergents play an essential role when extracting, purifying and manipulating membrane 
proteins. With an amphiphilic nature that allows them to interact with the hydrophobic 
domain present in membrane proteins, they manage to keep them water soluble outside 
of their native bilayer environment. 
 
A golden standard rule for the use of detergents in membrane protein studies and appli-
cations does not exist, due to their heterogeneity and complexity. For example, a deter-
gent useful for extraction may not be compatible with purification or biochemical studies 
[14], or a detergent that works for one membrane protein may not be suitable for another. 
Understanding the physicochemical properties associated with different classes of de-
tergents can be useful when deciding which of them may work best for a particular ap-
plication. Detergents are usually essential in the isolation and purification of the protein 
and are used in the primary solubilization step. They are also invaluable in membrane 
protein crystallization [11]. 
Detergents are amphipathic molecules that consist of a polar head group and a hydro-
phobic tail (Figure 4A). A few detergents, however, have been described as having a 
bean-like molecular shape, by containing both polar and nonpolar “faces” (Figure 4B). 
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How they are constructed results of vital importance because it provides the detergent 
with the ability to interact with biological structures and alter their specific functions, as 
in the case of biomembranes [15].  
 
 
Figure 4.  Detergent monomer, representing the most common detergents, with a hydrophilic 
head group and a hydrophobic tail or chain. [11] 
Detergents present unique properties in aqueous solutions, generally forming spherical 
micellar structures in a spontaneous manner (Figure 5). What detergents do is that they 
solubilize these membrane proteins by mimicking their natural lipid bilayer environment 
[11]. 
Figure 5.  Spontaneous micellization of detergents in hydrophilic solutions, forming spherical mi-
cellar structures.[11] 
Detergents belong to a class of surface active agents called surfactants, as they reduce 
the interfacial surface tension of water [15]. In biochemistry, they are used in different 
applications such as polyacrylamide gel electrophoresis (PAGE, the detergent SDS is 
used a potent protein denaturant), membrane solubilization and permeabilization, inclu-
sion body solubilization and lipid raft preparation. For the study of membrane proteins, 
detergents play a major role in their solubilization from the membrane, manipulation in 
aqueous solution and crystallization.  
In the study of membrane proteins, the selection of the detergent to use mainly depends 
on the type of work to be performed. For this matter, when choosing the most apt deter-
gent, the main characteristic of each detergent is its critical micelle concentration (CMC), 
which is the minimum concentration of detergent above which monomers assemble to-
gether, forming micelles [16]. This leads to a sudden change in some physicochemical 
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properties like the surface tension [11]. Hence, knowing the CMC is necessary to esti-
mate how much detergent is required in terms of preparation of various protein and mem-
branes. Likewise, when manipulated in detergent solution a membrane protein, the de-
tergent should always be at a concentration higher than its CMC, to insure the correct 
shielding of the hydrophobic domain of the membrane protein from water. 
 
Since the excess of detergent used to solubilize membrane proteins can complicate the 
spectra or disrupt further experimental work, it must be often removed once the proteins 
are solubilized. Various removal methods exist to allow transfer of the membrane protein 
into a liposome or into a different detergent, which take advantage of the properties of 
the detergent being used, such as the CMC, the charge or the aggregation number. 
Among these methods dialysis, hydrophobic adsorption, gel chromatography, ion-ex-
change chromatography and nickel columns are found [11]. 
 
2.2 Bacteriophages 
Bacterial viruses, known as bacteriophages or ‘phages’ were found in the beginning of 
the 20th century, when a British pathologist Frederick William Twort described a glassy 
transformation of Micrococcus colonies by a transmissible agent in 1915. Among the 
other proposed explanations, one suggested that the described agent was viral in nature. 
On the other hand, in 1917 a French Canadian named Félix Hubert d’Hérelle working at 
the Pasteur Institute (Paris) observed and described the lysis of Shigella cultures. Re-
gardless of the decades Twort dedicated trying to propagate vertebrate viruses on inert 
media, he did not pursue his discovery, mainly due to scarse funding during war time. 
Nonetheless, D’Hérelle did acknowledge the viral character of his agent and devoted his 
life to it: he invented the term bacteriophage, “bacterial eater”, proposed that viruses 
multiplied intracellularly and introduced phage therapy of infectious diseases. In 1940, 
the development of the electron microscope enabled the recognition of the viral nature 
of bacteriophages [17]. 
Bacteriophages have been the center of many studies since their discovery. In particular, 
they have allowed the development of modern genetics and of molecular biology [18]. 
Furthermore, they have been used for over 90 years as an alternative to antibiotics in 
the Eastern countries due to their capacity of being used for infectious diseases treat-
ment, representing a possible therapy against multi-drug-resistant strains of many bac-
teria [19]. 
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They are one of the most common and diverse agents in the environment, and phages 
are indeed found wherever bacteria exist, therefore they have co-evolved with bacteria, 
turning into virulent pathogens and, thus, have a great impact on their hosts [20]. 
2.2.1 Classification and the structure of bacteriophages 
Phages are classified into 13 families and 30 genera, as seen in Table 1. 
Table 1. Classification of bacteriophages based on their shape and properties [15]. 
 
Bacteriophage virions can be tailed, polyhedral, filamentous or pleomorphic. As shown 
in the table 1, most of the phages possess dsDNA, but some small phage groups present 
with ssDNA, ssRNA or dsRNA [17]. More than 95% of the bacteriophages identified be-
long to the caudovirales order (Figure 6.).  
Figure 6. Caudovirales or tailed bacteriophages structures: Myoviridae in 2D and 3D (left), Podo-
viridae (middle) and Siphoviridae (right). 
Morphologically, they possess a head-tail structure that is unique in virology. The head 
is icosahedral with cubic symmetry, in a capsid enclosing a dsDNA densely packed. The 
tail is a dynamic multi-proteic assembly that gives them the capacity to recognize the 
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surface of the bacteria, allowing the delivery of their genome into the host cell [20]. These 
tailed phages probably represent the most diversified of all the bacterial virus groups. 
The morphology of their tail has allowed them to be further classified in three families: 
Myoviridae (25% of tailed phages), with a long contracting tail consisting of a sheath and 
a central tube; Podoviridae (14%), with a short non-contractile tail; and Siphoviridae 
(61%), with a long flexible non-contractile tail [17]. 
Depending on the genome structure, concatemer formation, unusual bases, DNA or RNA 
polymerase genes and DNA sequence, 15 genera are grouped with vernacular names: 
groups T4, P1, P2, Mu, Mu, SPO1, H from the Myoviridae family; groups, T1, T5, L5, c2, 
ψM from the Siphoviridae and groups T7, P22, φ29 are part of the Podoviridae family 
[17]. 
2.2.1.1 Coliphage T5 
In the study of phage-host interactions, the coliphage T5 from the Siphoviridae family 
(Figure 7.) has proven to be a great model, since its Receptor Binding Protein (RBP) pb5 
and its receptor FhuA have both been identified and purified. Additionally, the pb5-FhuA 
interaction is enough to induce DNA ejection and the purified pb5-FhuA interaction pro-
duces a highly stable, stoichiometric complex [5]. This stable complex is presently the 
only outer membrane receptor - phage RBP complex biochemically available [20]. 
 
Figure 7. T5 (Type 5) structure. Left: negative stain Electron Microscopy; Right: 3D reconstruction 
from cryo-EM [18]. 
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It possesses a 250 nm tail ends (light blue) with three L-shaped fibers (yellow) attached 
to a conical baseplate (orange) and a straight central fiber (yellow protrusion from the 
orange cone) [21]. 
The host recognition occurs through reversible binding of the L-shaped fibers to the LPS 
O-antigen. Irreversible binding of the phage to the iron-ferrichrome transporter FhuA in 
the outer membrane then follows, through its RBP pb5. Interestingly, T5 is able to trigger 
DNA release in vitro in the external medium, only by interacting with the purified FhuA or 
liposomes containing FhuA [22].  
2.2.2 Infection Process of Bacteriophages 
When bacteriophages infect a bacterial cell, they can enter two different life cycles: the 
first mode of reproduction (the lytic cycle) is to control the machineries of the host bac-
terial cell for replication, transcription and translation to make complete viral particles, 
while the second one, the lysogenic cycle, is to silently integrate its DNA into the bacterial 
chromosome and be transmitted to the daughter cells. These “prophages” can wake up 
under stress conditions and enter a lytic cycle before the host dies. The genes for some 
toxins are encoded in a prophage, allowing the host bacterium to become pathogenic 
[23]. Those phages able to undergo this lysogenic cycle are known as temperate phages. 
 
Figure 8. Scheme concerning the infection mechanism of a bacteriophage. Step 1: To be able 
to enter a host cell, bacteriophages attach to specific receptors present on the bacterial surface. 
The RBP-receptor interaction generates different conformational rearrangements that occur in-
side of structures such as the tail [20], in the case of Caudovirales. This stimulates the capsid 
to open and the cell wall to be perforated, allowing DNA to be released and transferred via the 
tail to occur across the bacterial envelope. The host range of different bacteriophages regulates 
the attachment’s specificity. Step 2: Bacterial RNA polymerase starts to transcribe viral DNA 
tanks to very strong promoters, and ribosomes translate within minutes the viral mRNAs into 
proteins. Step 3: The whole metabolic machinery of the cell is high jacked by the viral DNA, and 
is turned into a viral factory. Step 4: Finally, virions are released via extrusion, cell lysis or bud-
ding becoming capable of infecting another bacterium. 
Bacteriophage T5 is able to prevent overinfection by other T5 phages by blocking the 
FhuA receptor protein, by means of a lipoprotein that is expressed early during infection 
[21]. A few viruses are capable of carrying out both cycles. An example is the phage 
lambda of E. coli. 
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There are different types of recombination events that can lead to the incorporation of 
bacterial DNA into the viral DNA, leading to two modes of transduction specialized and 
generalized. The first one refers to an “excision” event: a lysogenic phage infects the 
bacterium and viral DNA is incorporated into the bacterial chromosome. When the phage 
DNA is excised, the flanking bacterial genes may be excised with it. 
On the other hand, generalized transduction denotes a packaging event, where the lytic 
phage cleaves the bacterial DNA. In this process, parts of the bacterial chromosomal 
DNA may become packaged in viral capsid. When the phage later infects another bac-
terium, the transfer of these genes occurs. It typically carries only bacterial DNA, instead 
of viral DNA [23].  
As seen in Figure 9., the process of transduction is carried out in several steps: In a first 
step the phage makes contact with the host bacterial cell, which contains its intact chro-
mosomes, followed by the breakage of the host DNA through phage enzymes. In steps 
3 and 4, the cell creates new phages that include the phage and host DNA. After this, 
the insertion of the donor DNA by the transducing phage is seen in the steps 5 and 6, 
obtaining a final transduced bacterium with the donor DNA included in the recipient’s 
chromosome in step 8, through a process known as recombination.  
 
Figure 9.   Process of transduction, consisting in the transfer of DNA from one bacterium to an-
other through a virus, known as bacteriophages 
Besides this process, DNA exchange can occur through other three mechanisms in pro-
karyotes: binary fission, transformation and conjugation. In the case of binary fission, it 
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represents the most common form of reproduction in prokaryotes and occurs in an asex-
ual manner, where a cell splits into two halves, thereby leading to the production of two 
new cells. As for transformation, it refers to the ability of bacteria to take up naked pro-
karyotic DNA from the environment, produced by cell lysis for example. In transformation, 
any DNA can be used. Finally, conjugation refers to the transfer of DNA from one cell to 
another, occurring after the pilus draws the two bacteria near enough to form a bridge 
that connects them, therefore allowing their mating [23]. 
2.2.3 Phage Injection Process 
The binding of the phage into the bacteria and the infection mechanism (Figure 10.) is 
studied with great interest due to many possible future applications, as it is the case of a 
therapy based on the use of phages. 
 
Figure 10. DNA injection process by a bacteriophage during transduction. First, the bacteriophage 
binds to the host cell surface to specific receptors like LPS, then once it is attached 
completely, the binding becomes irreversible and the tail contracts. This allows for the 
genetic material to be injected through the bacterial cell membrane, with the use of a 
receptor. 
Each phage exhibits RBPs (Receptor Binding Proteins), located at the tip of the tail in 
Caudovirales. These determine the host specificity of the phage depending on their in-
teraction with certain receptors present at the surface of the bacteria, either proteins or 
sugars. The structure of phage tail subcomplexes varies between different families and 
groups. In the case of the T5 coliphage, irreversible attachment is achieved when the 
phage tail protein pb5 associates with the outer membrane protein receptor FhuA [24]. 
14 
  
In a previous study, the complex formed between these two proteins: pb5 and FhuA, was 
further characterized: the formation of the complex causes the strength of interaction and 
upon formation of the complex, conformational changes occur, particularly in pb5. Also 
pb5 was noticed not to share the common features with other known RBPs [20]. 
2.3 Lama Antibodies 
VHH (Variable Domain of Heavy-Chain Antibody or hcAb) antibodies are antibodies 
taken from the serum of animals from the Camelidae family, specifically lamas. The char-
acteristics of these antibodies is that they lack light chains usually found in mammal 
antibodies. Their increase use in structural biology is due to these domains, which are 
easy to clone and express in bacteria, and functionally they are able to bind antigens as 
effectively as mammal antibodies (Figure 11). VHHs also contain an extra second disul-
fide bridge that links CDR1 and CDR3, which gives the aforementioned stabilization to 
the VHH. However, it might also allow the formation of a new loop that could recognize 
an augmented variety of epitopes [25]. 
 
Figure 8. The structure of (a) a classical antibody versus (b) a lama antibody. 
During crystallization, it is possible to increase the soluble surface of the complex using 
these small proteins to optimize the crystallization with easily aggregating proteins, such 
as pb5. 
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2.4 Crystallization of Membrane Proteins 
The knowledge of the protein structure at a molecular level is necessary for the under-
standing of membrane functions. In the present, X-ray crystallography following the crys-
tallization of the protein is the most accurate way to obtain structures in the field of struc-
tural biology. For this matter, obtaining three-dimensional crystals is necessary in order 
to perform X-ray crystallography [3].  
Even though in vitro studies, such as crystallization for membrane proteins, can be per-
formed, they are very dependent on the effective solubilization with detergents and mixed 
lipid/detergent systems and reconstitution of the membrane proteins [11]. As a result, the 
study of membrane proteins still represents a big challenge. The problems faced while 
working outside of their natural lipid environment is one of the major difficulties. 
Overall, obtaining structures of membrane proteins, the main obstacle relies on the prep-
aration of crystals of diffraction quality. In the production of proper three-dimensional 
crystals there is a variety of techniques, based on the use of lipid micelles or detergent 
and lipid systems [11]. 
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3 Materials and methods 
The project was performed by overexpressing, purifying and characterizing three differ-
ent proteins FhuA, pb5 and VHH antibodies. A detailed scheme is presented in figure 
12. 
 
 
Figure 9. The flow chart of the project.  
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3.1 Overexpression 
The overexpression of the studied proteins was performed in E. coli. First, a preculture 
was prepared in LB broth, using a glycerol stock and the inoculation took place after an 
overnight growth, until OD600 was 0.1, both in 180 rpm agitation. After overnight growth, 
the cultures were centrifuged at 4°C for 20 min, at 5000 rpm in the JLA8-1000 rotor and 
the recovered pellets were frozen in liquid nitrogen and stored at -80 ° C. The details of 
the overexpression are presented in table 2.  
Table 2. Overexpression of the studied proteins FhuA, pb5 and VHH antibodies. 
Overexpressed 
protein 
Strain Media Antibiotic 
Tempera-
ture 
Induction 
FhuA AW740 LB/TB 
Ampicillin 125 µg/ml 
Tetracycline 10 µg/ml 
37°C 
Dipyridyl 100 
µg/ml during 
inoculation 
pb5 BL21(DE3) LB Kanamycin 50 µg/ml 20°C - 
VHH WK6 TB Ampicillin 100 µg/ml 37°C 1 mM IPTG 
 
The E.coli  strain AW740 for overexpressing FhuA, lacking two major porines OmpF and 
OmpC, mutated for endogenous fhuA and has resistance to Tetracycline (Tet). This 
strain is transformed with plasmid pHx405-His-FhuA, which carries the FhuA gene under 
the control of its own promoter and having a hexahistidine tag inserted into the FhuA 
gene after amino acid 405 at an exposed loop.  Pb5 is overexpressed in the E. coli strain. 
coli BL21 (DE3) transformed with the plasmid pET-28b, in which the oad gene was 
cloned. This construct allows the fusion of a 6-His tag at the C-terminus end of pb5. For 
VHH antibodies, E. coli strain; WK6 (galE, strA, mutS215::Tn10(Tet)R, Δ (lac-proAB) 
[F'traD36 proAB lacIqZΔM15]) is used, containing a plasmid vector; pHEN6 encoding an 
N-terminal pelB signal sequence in frame with a cassette expression and C-terminal 
6xHis detection and purification tag [26].  
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3.2 Protein Purification 
All the different purification steps (table 3.) were performed with Biologic DuoflowTM –
system (Bio-Rad), including two pumps, an UV/Vis detector and an automatic sample 
collector.  
 
Table 3. The summary of the protein purification protocols for the studied proteins. 
Protein 
Chroma-
tography 
Column Equilibration buffer Elution buffer Flow rate Other buffers 
Flow 
rate 
Fraction 
size 
 
FhuA 
 
Nickel affi-
nity chro-
mato-
graphy 
5ml 
HiTrapTM 
Chelating 
HP 
20 mM Tris pH 8, 5 
mM imidazole, 0.1 % 
LDAO 
20 mM Tris pH 
8, 200 mM imid-
azole, 0.1 % 
LDAO 
2 ml/min 
Delipidation: 
20 mM Tris 
pH 8, 5 mM 
imidazole, 1% 
LDAO 
0.2 
ml/min 
1 ml 
Cation ex-
change 
HiTrapTM Q 
HP 1 ml 
20 mM Tris pH 8, 
0.05 % LDAO 
7 ml of 20 mM 
Tris pH 8, 1 M 
NaCl 0.05 % 
LDAO 
Gradient 
0.3 ml/min 
-  1 ml 
pb5 
 
Nickel af-
finity chro-
matog-
raphy 
HiTrapTM 5 
ml Chelating 
HP 
50 mM Tris pH 8, 250 
mM NaCl, 15 mM im-
idazole 
1. Elution 
buffer: 25 mM 
MES pH 6, 200 
mM EDTA 
5 ml/min 
2. Elution 
buffer: 25 mM 
MES pH 6, 50 
mM EDTA, 
250 mM NaCl 
0.25 
ml/min 
1 ml 
Anion ex-
change 
HiTrapTM 1 
ml SP HP 
25 mM MES pH 6 
25 mM MES pH 
6, 1 M NaCl 
Gradient 
0.7 ml/min 
  0.5 ml 
VHH 
 
Nickel af-
finity chro-
matog-
raphy 
HiTrapTM 5 
ml Chelating 
HP 
50 mM Tris pH 8, 0.5 
M NaCl, 20 mM Imid-
azole 
50 mM Tris pH 
8, 0.3 M NaCl, 
250 mM Imidaz-
ole 
5 ml/min -  1 ml 
Sixe exclu-
sion chro-
mato-
graphy 
Super-
dexTM 75 
10/300 GL 
- - - 
20 mM Tris 
pH 8, 250 mM 
NaCl 
0.5 
ml/min 
1 ml 
 
3.2.1 Purification of FhuA 
When the bacterial ferrichrome transporter FhuA was purified, first a frozen cell pellet , 
resulting from one liter of cell culture, was thawed and lysed with lyse buffer (50 mM Tris 
pH 8, 150 mM NaCl, 2 mM MgCl2 with DNAse and CLAPA), the cells were passed 10 
times through a cell microfluidizer machine at 15 000 psi. To remove the cell debris, the 
sample was centrifuged for 6 000 rpm, 15 min in 4°C with a JA 25.50 rotor, the pellet 
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was discarded, and the supernatant was ultracentrifuged for 28 000 rpm, 30 min, 4°C 
(45Ti rotor). 
After the second ultracentrifugation, the pellet containing the membranes of the bacteria 
was resuspended into Tris 50 mM pH 8, 2 % OPOE and incubated in 37°C in agitation 
for 30 min. 
Then the sample was centrifuged again for 28 000 rpm, 30 min, in 4°C (45Ti rotor) and 
the pellet, containing the non-solubilized bacterial outer membrane, was suspended into 
50 mM Tris pH 8, 1 % LDAO and incubated for an hour in 37°C, followed by an ultracen-
trifugation with 45Ti rotor (28 000 rpm, 30 min, 4°C). 
Finally, the last supernatant was collected and 2 mM MgCl2 and 5 mM Imidazole were 
added.  
During the membrane purification, an aliquot was taken from the supernatants and pel-
lets, which were later loaded into a 10 % SDS-PAGE gel (200 V) stained with Coomassie 
blue. 
a) Affinity Chromatography 
The outer membrane solubilization supernatant was loaded into a nickel affinity column 
(5 ml HiTrapTM Chelating HP, GE Healthcare) which was equilibrated with 20 mM Tris 
pH 8, 5 mM imidazole, 0.1 % LDAO and after sample injection (5 ml/min) the column 
was delipidated with a buffer with a higher detergent concentration 20 mM Tris pH 8, 5 
mM imidazole, 1% LDAO for 0.2 ml/min, 20 ml. The system was washed with 20 mM 
Tris pH 8, 5 mM imidazole, 0.1 % LDAO and the protein was eluted in the end with a 
high concentration of imidazole using 10 ml of 20 mM Tris pH 8, 200 mM imidazole, 0.1 
% LDAO 2 ml/min. During the sample injection the flow through and in the elution step, 
1 ml fractions were collected and the fractions containing FhuA were pooled together. 
b) Anion Exchange Chromatography 
 
The second purification step for FhuA sample, fractions containing the protein from the 
previous chromatography step, was a cation exchange chromatography (column: 
HiTrapTM Q HP 1 ml, GE Healthcare). First, the system was equilibrated with 20 mM Tris 
pH 8, 0.05 % LDAO followed by the sample injection with 2 ml/min flow rate, the flow 
through was collected as well. The column was washed with the equilibration buffer and 
then elution was performed with linear gradient, increasing the salt concentration with 7 
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ml of 20 mM Tris pH 8, 1 M NaCl 0.05 % LDAO, for 0.3 ml/min flow fate. During the 
elution, 1 ml fractions were collected by the automatic sample collector. 
After the purification, the fraction concentrations were determined with UV/Vis spectro-
photometer. A 10 % SDS-PAGE, 200 V was performed with silver staining to determine 
its LPS (lipopolysaccharide) content. 
3.2.2 Purification of pb5 
When T5 RBP pb5 is purified, the frozen cell sample is first thawed and suspended into 
lyse buffer [50 mM Tris pH 8, 150 mM NaCl, 2 mM MgCl2 with DNAse and CLAPA 
(CLAPA: 1 ug each of chymostatin, leupeptin, antipain, and pepstatin per ml and 8 ug of 
aprotinin per ml)]. After, the lysed cells were sonicated in 2 s cycles with 10 s pause for 
total 28 min with 70 % power. 
To get rid of non-broken cells, the cell debris and membranes in the sample, the cells 
were ultracentrifuged 30 000 rpm, 20 min, 4°C with a JA 25.50 rotor. After the centrifu-
gation, 100 mM NaCl and 15 mM imidazole were added to the collected supernatant and 
it was used as a sample in the following steps. 
a) Nickel Affinity Chromatography 
 
The affinity column (GE Healthcare HiTrapTM 5 ml Chelating HP) was equilibrated with 
an equilibration buffer containing 50 mM Tris pH 8, 250 mM NaCl, 15 mM imidazole, 
which was followed by the sample injection, for 5 ml/min. After, the column was washed 
with 45 ml equilibration buffer for 5 ml/min. The elution of the protein was performed by 
adding EDTA to the system using two elution buffers: a) 25 mM MES pH 6, 200 mM 
EDTA and b) 25 mM MES pH 6, 50 mM EDTA, 250 mM NaCl. During the elution, 1 ml 
fractions were collected automatically by the fraction collector of the instrument. 
Collected fractions were ran in 10 % SDS-PAGE gel, 200 V stained with Coomassie 
blue. 
b) Cation Exchange Chromatography 
 
For the cation exchange chromatography, fractions from affinity chromatography con-
taining pb5 were pooled together and diluted ten times with 25 mM MES pH 6 to de-
crease the sample salt concentration. The equilibration of the column (GE Healthcare, 
HiTrapTM 1 ml SP HP) was done with 25 mM MES pH 6. Sample injection was performed 
with 0.7 ml/min flow rate after the column was fully equilibrated, followed by washing the 
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column with the equilibration buffer with1 ml 0,70 ml/min. The elution was done using a 
linear gradient with increasing salt concentration until 1 M NaCl. During the elution, 0.5 
ml fractions were collected and the most concentrated ones were diluted with 25 mM 
MES pH 6, 50 mM NaCl to avoid protein precipitation. 
After the purification step, 10 % SDS-PAGE, 200 V, with Coomassie blue staining, was 
performed with the collected fractions and the flow through of the sample injection. Ad-
ditionally, the concentrations of the protein containing fractions were measured with 
UV/Vis spectrophotometer. 
3.2.3 Purification of the Lama Antibodies 
Because during the overexpression of the VHH antibodies, the proteins are transferred 
and stored in the periplasmic space, to break the outer membrane of the bacteria, and 
to release the protein, a frozen bacterial pellet was suspended into a sucrose buffer (100 
mM Tris pH 8, 0.5 M saccharose, 20 mM imidazole) and then centrifuged for 13 000 g, 
15 min, 4°C (JA 25.50 rotor). This first supernatant was collected, and the pellet was 
resuspended in water and incubated in ice for 10 min. Before a second ultracentrifugation 
(13 000 g, 15 min, 4°C, JA 25.50 rotor) 1 mM of MgCl2 was added. After the centrifuga-
tion, the obtained, second supernatant was collected as well.  To ensure which of the 
supernatants contains the studied proteins, the aliquots of the both collected superna-
tants were loaded into a 15 % SDS-PAGE (200 V), stained with Coomassie blue. As a 
result, the supernatants were pooled together and solutions of Tris 20 mM pH 8 was 
added as 20 mM imidazole.  
a) Nickel Affinity Chromatography 
 
At first, the equilibration of the column (HiTrapTM 5 ml Chelating HP, GE Healthcare) was 
done with 50 mM Tris pH 8, 0.5 M NaCl, 20 mM Imidazole, followed by the sample injec-
tion for 3 ml/min, during this step, the flow through was collected as well. The column 
was washed with 20 ml of equilibration buffer with 5 ml/min flow rate. During the elution 
with 50 mM Tris pH 8, 0.3 M NaCl, 250 mM Imidazole, 1 ml fraction were collected, which 
were later loaded into 15 % SDS-PAGE (200 V), stained with Coomassie blue. 
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b) Size Exclusion Chromatography 
 
After the affinity chromatography, the NiNTA fractions were concentrated until 500 l with 
3 kDa concentrator (Amicon® Ultra-4 Centrifugal Filter Units, Millipore), and then loaded 
into SuperdexTM 75 10/300 GL (GE healthcare) column to perform Size Exclusion Chro-
matography (SEC). The used buffer was 20 mM Tris pH 8, 250 mM NaCl with 0.5 ml/min 
flow rate. 
Later the concentrations were measured with UV/Vis spectrofotometer and the obtained, 
1 ml fractions from the elution were ran in 15 % SDS-PAGE (200 V) with Coomassie blue 
staining. 
3.3 Complex Formation and the Detergent Exchange  
For the formation of the FhuA-pb5-VHH complex, all the three proteins were mixed to-
gether in 1:1:1 molar ratio. To perform an exchange of the detergent, the complex was 
diluted ten times in water and incubated in 4°C over night until aggregation occurred. 
After the incubation, the sample was ultracentrifuged 35 000 rpm, 30 min, 4°C and the 
small pellet was carefully resuspended into 20 mM Tris pH 8, 1.6 % C10DAO buffer. 
The success of the complex formation was determined with 10 % SDS-PAGE with 200 
V and Coomassie blue staining, by loading heated (reduced protein) and non-heated 
(non-reduced protein) complex sample on the gel. 
3.4 Crystallization 
To screen different crystallization environments for the studied protein complex, two dif-
ferent methods were used. To screen small numbers of conditions, previously defined 
as producing crystals, the crystallization plates were prepared manually (see 3.4.1.) and 
for larger amounts of conditions to be screened, the samples were sent to HTX platform 
(see 3.4.2.), where the crystallization plates were done by a crystallization robot Carte-
sian PixSys 4200. 
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3.4.1 48-Well Crystallization Plate 
When a crystallization plate was prepared by hand; 0.8 µl of protein complex was mixed 
with 0.8 µl of precipitant reagents with varying salts, pH, and PEG 3350 concentrations. 
The drop of the reagent-protein mixture was placed as a hanging drop in a well contain-
ing the used reagents. In that case, the drop is carefully set on a small glass cover slip, 
that is then placed on top of the well, thus sealing it, the drop hanging on the inside, in 
an upside-down manner.  
The plates were stored in 4°C and they were observed with an inverted microscope 
daily during the first week and followed less rigorously afterwards, until the last sched-
uled inspection. 
3.4.2 HTX platform 
To send samples into the HTX (High Throughput Crystallization) platform in The Euro-
pean Molecular Biology Laboratory (EMBL), Grenoble, the amount of protein should be 
sufficient (usually 5-10 mg/ml), and the required volume is 15 µl of sample per plate 
In the platform, the Olympus CKX53 robot mixes 100 nl of precipitant reagents with 100 
nl of the protein sample, placing them on a 96 well plate, three or two drops per well, by 
an automated high throughput system. 6 classical and complementary screens were 
used.  
The plates were stored in 4°C, and pictured with the following schedule: 1st, 3rd, 7th, 
15th, 33rd, 61st and 87th day, by the automated imaging system (RockImager (Formu-
latrix, Inc., U.S.)). It photographed the drops and sent them via email, when it was pos-
sible to access and characterize the drops with an account in the website of the HTX lab. 
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4 Results and discussion 
4.1 Purification 
In a first approach, with the use of transformed E. coli cells, the protein was overex-
pressed, with different techniques depending on the protein of interest in each case by 
following the steps in materials and methods.  The cells were later lysed, and the sample 
was purified by chromatographic methods to obtain the studied protein.  
The protein yields are presented in table 4., as seen, not so much protein was obtained 
per liter of cell culture especially with the tail tip protein pb5 and the antibodies. 
Table 4. Yields of the studied proteins FhuA, pb5 and the VHH antibodies. 
Protein Yield (mg/ml) 
FhuA 11.6 
pb5 2.5 
pb5 0.4 
pb5 3.6 
pb5 5.7 
VHH53 0.2 
VHH64 0.1 
VHH81 0.6 
4.1.1 Purification of FhuA 
The purification of FhuA was monitored in different steps by taking aliquots from pellets 
and supernatants, which were loaded onto a 10% SDS-PAGE GEL (200 V). In figure 12 
the different steps of the purification are observed, with the FhuA expected to show a 
band at 80 kDa. Lane a shows the cytosolic proteins, whereas lane b corresponds to the 
total membranes. Lanes c and d correspond to the supernatant and pellet of the OPOE 
solubilization of the total membranes. In these conditions, the inner membrane is mainly 
solubilized, and indeed, FhuA, of the outer membrane, is recovered in the insoluble pel-
let. Lanes e and f correspond to the supernatant and pellet of the LDAO solubilization of 
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the OPOE insoluble membranes. In these conditions, FhuA is recovered in the superna-
tant 
 
Figure 12. 10 % SDS-PAGE (200 V). The supernatant (a) 
and the pellet (b) were loaded into the wells after the first 
ultracentrifugation, whereas the supernatant and the pellet 
with OPOE 2% were loaded into c and d, respectively. The 
last obtained supernatant (e) and the pellet (f) correspond to 
the step where LDAO 1% was used as a detergent. 80 kDa 
is the molecular weight corresponding to FhuA 
 
 
This supernatant is further purified on NiNTA that retains proteins with a polyHistidine 
tag and ion exchange chromatographies. During the chromatographic purification, the 
elution of the protein is followed by an UV/Vis detector, and the fractions containing pro-
tein are visible as an increase of the A260 absorption in figure 13., it is possible to see the 
elution of the protein (green line) as two peaks in Nickel affinity chromatography (left) 
and in the anion exchange (right). In the case of NiNTA, an elevation preceding the elu-
tion peaks can be seen, due to the other proteins that are not interacting with the column 
but eluted during the sample injection.  
 
Figure 10. FhuA purification. of FhuA in the Left: NiNTA, right: anion exchange chromatography. 
The wavelength signal 280 (green) corresponds the protein elution. In the second step, 
the protein elutes in two peaks; one containing LPS and the other one not containing 
it. The red shows the conductivity, which means the salt concentration increases dur-
ing in the column resulting elution of the ion exchange chromatography following the 
NaCl gradient, inducing protein release from the column. 
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Also, as a consequence of the linear gradient during the ion exchange chromatography 
elution, the increasing salt concentration is also visible (red curve). This occurs when the 
elution buffer, which contains a high salt concentration, flows through the column, lead-
ing to a competition for the binding to the column between the negative ions with FhuA, 
with a final elution of the protein. 
In the anion exchange, the two protein peaks seen in the elution profile presumably rep-
resent either the presence of the protein alone (first peak) versus the protein bound to 
LPS (second peak), with the fractions forming the first peak being preferred for forming 
the protein complex later on, due to the absence of LPS. However, to determine the 
presence of LPS, the fractions are further analyzed by SDS-PAGE, stained by silver stain 
to assess the presence and quantity of LPS and another gel stained by Coommassie 
blue to assess the purity of the obtained protein. 
For this reason, after the anion exchange was performed, the fractions expected to con-
tain the FhuA protein bound to LPS were either heated or not, and loaded onto a 15% 
SDS-PAGE (Figure 14.), as detailed in materials and methods, where 0.5 µg, 1.0 µg and 
2.0 µg of LPS were used as control (lanes a to c, respectively). Of each fraction, 2 µg of 
non-heated FhuA, followed by 2.0 µg of heated FhuA and finally 8.0 µg of non-heated 
FhuA were loaded into the gel (lanes d-l).  
 
Figure 114. a-c LPS 0.5 µg, 1.0 µg, and 2.0 µg respectively; d-f FhuA 2.0 µg non-heated of frac-
tions 11-13, g-i FhuA 2.0 µg heated, j-l FhuA 8.0 µg non-heated. 15% SDS-PAGE, 200 
V, silver staining. The amount position of LPS is shown around 10 kDa.  In the loaded 
fractions there is J-k 1.0 µg and l around 2.0 µg of LPS when compared to the control. 
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4.1.2 Purification of pb5 
The protein purification for the tail tip protein pb5 was followed with a UV-Vis detector 
during its elution. The supernatant of broken cells was loaded onto a NiNTA column, and 
eluted by nickel chelation by EDTA and low pH: two peaks are visible (Figure 15 A), 
therefore the fractions were assessed with a 10% SDS-PAGE. The fractions that resulted 
in 70 kDa bands (Figure 15 B) corresponded to pb5 and were then pooled and loaded 
onto a cation exchange chromatography (Figure 15 C). The most concentrated and pure 
fractions were collected after and pooled, with their concentrations being measured later 
with UV-Vis spectrophotometer. It is important to be aware of how vital it is to proceed 
quickly to the next steps during the purification of pb5, since this protein has a tendency 
to precipitate alone very rapidly. 
 
 
Figure 12.  Pb5 purification A) left: chromatogram of the NiNTA elution; right, chromatogram of 
the cation exchange chromatography, the increased salt concentration causes the elu-
tion of the protein (red). In both panels, the green curve corresponds to absorption at 
280 nm of the elution. B) 10% acrylamide SDS-PAGE of the elution of the NiNTA col-
umn a: before loading to the column, b: flow through, c: wash of the column, d-n: the 
eluted fractions 13-20. C) The fractions after resulting from the cation exchange chro-
matography elution., a-b: are the wash, and c-n eluted fractions containing the purified 
pb5. 
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4.1.3 Purification of the Lama Antibodies 
The analysis for the four VHH antibodies were performed separately. Due to the use of 
the same protocols and the obtaining of the same results for each antibody, only the 
VHH53 graphs and gels are presented in figures 16 and 17, respectively.  
On a first step, the outer membranes were broken using osmotic shock. This step re-
sulted in the obtention of two supernatants: one after centrifugation after incubation in 
sucrose buffer and the second one after incubation in pure water. Lastly, the pellet was 
suspended in sucrose buffer and a small aliquot was taken and saved aside, in order to 
load on a 15% SDS-PAGE gel after all the purification steps. 
After lysis, the purification of the four different antibodies was started with an affinity 
chromatography on a NiNTA column (seen in figure 16, left). Later, Size Exclusion chro-
matography (SEC) was performed (seen in figure 16, right) to separate the antibodies 
from possible contaminants by their size.  
 
Figure 13. Purification chromatograms for the lama antibodies. Green signal: eluted protein 
(wavelength 280 nm). Affinity chromatogram, elution (left) and SEC (right) showing 
one peak corresponding to the VHH antibodies. The blue arrow represents the void 
volume, and the total volume of the column is marked with a black arrow. The grey line 
in the background shows the wash of the column and the elution of imidazole (wave-
length 214 nm).   
Subsequently, the aforementioned aliquots taken before the purification process were 
loaded onto a 15% SDS-PAGE gel at 200 V (Figure 17, lanes a-c). Normally, if the used 
protocol for osmotic shock is considered, the lama antibodies should be found in the last 
supernatant. However, the studied protein was found to show a band in both of the su-
pernatants (lanes a and b), presumably as an effect of either the freezing process or the 
29 
  
age of the cells. Hence, they were pooled together to proceed towards the chromato-
graphic purification. As for the pellet (lane c), it was discarded for not containing the 
studied protein, as expected.  
Next to these three lanes, the eluted protein fractions were also loaded into the same gel 
electrophoresis (Figure 17, lanes a-c), in order to monitor the success and the purity of 
the sample. In the same manner, after the second purification step by SEC the fractions 
are analyzed by SDS-PAGE (Figure 17, lanes j-n). A band can be seen at a molecular 
weight of around 12 kDa, corresponding to the VHH. showing a concentrated and pure 
protein.  
 
Figure 14. 15% SDS-PAGE, 200 V. a-b: supernatants obtained after cell lysis by osmotic shock 
showing a faint band for the antibodies at 12 kDa; c: pellet after the cell lysis; d: flow 
through in the affinity chromatography; d-h: the fractions 10-13, obtained from the af-
finity chro-matography; i: an aliquot from the concentrating of the sample between the 
purification steps; j-n: fractions from size exclusion chromatography, where the protein 
is eluted in two very concentrated and pure fractions seen in lane j and k only (fractions 
8-9). 
4.2 Complex Formation 
Table 5. presents the different complexes formed in the project. The concentrations were 
measured with the NanodropTM instrument. Different trials were attempted that included 
older protein samples from the research laboratory, as well as newly purified fresh pro-
teins. The complexes were sent to the High Throughput Crystallization (HTX) laboratory 
whenever a sufficient concentration (around 10 mg/ml) was obtained. 
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Table 5. Crystallization plates preparation 
Complex 
Concentration 
(mg/ml) 
Crystallization method To notice 
FhuA- pb5-
VHH64 
4.45  Old, previously 
FhuA- pb5-
VHH81 
6.9 48-well plate purified FhuA 
pb5-VHH64 5.4  and antibodies 
FhuA-pb5-
VHH53 
8.17  were used with 
FhuA-pb5-
VHH54 
8.0  freshly purified pb5 
pb5-VHH81 1.41   
FhuA-pb5-
VHH53 
6.7   
FhuA-pb5-
VHH54 
6.7   
FhuA-pb5-
VHH64 
6.9 HTX  
FhuA-pb5-
VHH81 
5.7  
All freshly purified 
proteins 
pb5-VHH53 5.7   
pb5-VHH64 2.3   
pb5-VHH81 6.5   
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The success of the 1:1:1 protein complex formation was assessed with a 10% SDS-
PAGE gel (Figure 18.), where the complexes are loaded either after being heated or not. 
The FhuA-pb5 interaction is very strong: indeed, it is not denatured by SDS, and migrates 
as a unique band (lane e). The two proteins are separated only when heated to 90°C for 
2 min (lane d). The heated sample shows FhuA, pb5 and the VHH, that can be located 
comparing migration with the individually loaded proteins: FhuA on lane a (80 kDa) and 
pb5 on lane c (70 kDa), where the faint band results from the low loading concentration. 
Also, the protein is not extremely pure. In the case of FhuA, it is interesting to see that 
the non-heated protein does no migrate at the same position as the heated sample. This 
is due to the fact that FhuA is not denatured by SDS alone, and thus migrates in the gel 
as a folded, more compact protein: it migrates faster than the denatured protein. The 
unique band in the non-heated complex demonstrates that the FhuA-pb5 complex has 
been successfully formed in a 1:1 ratio, with no visible excess of any of the studied pro-
teins in the complex. 
Figure 15. Assessment of the complex formation in a 1:1:1 ratio by gel electrophoresis. 10% SDS-
PAGE was ran at 200 V on a: FhuA non-heated, b: FhuA heated, c: pb5, d: FhuA-pb5 
heated, e: FhuA-pb5 non-heated. When the complex is heated, the com-plex is dena-
tured and the separated bands are shown in 70 kDa for pb5 and 80 kDa for FhuA. In 
the non-heated aliquot, the complex stays intact and only one band is visible. 
4.3 Crystallization 
The crystallization was monitored through the observation of the drops previously placed 
in wells as detailed in materials and methods, with an inverted optic microscope. Several 
trials were performed and often only aggregation and precipitation were seen (Figure 
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19.) and no crystals were formed in the droplets, as obtaining the formation of crystals is 
a known difficulty in the study of this protein complex. 
 
Figure 16. Example of the obtained drops. Made by hand (upper row) where the A and the C 
drops show protein precipitation, whereas an empty clear drop is seen in the B. In the 
case of the lower row, they were made in the HTX laboratory, where the drop D is clear 
with small impurities, the E demonstrates precipitation and the drop F shows small 
impurities and phase separation. 
On the other hand, few crystals were formed in the project, as seen in Figure 20., all of 
them produced by the HTX platform. Two droplets with the whole FhuA-pb5-VHH formed 
crystals: Some round crystals of FhuA-pb5-VHH64 complex (6.9 mg/ml) with 1 M Potas-
sium Sodium tartrate, as well FhuA-pb5-VHH53 (6.7 mg/ml) forming a single crystal with 
0,1 M Imidazole pH 8, 0.2 M Sodium chloride, 0.2 M sodium thiocyanate, 20 % w/v PEG 
335. Also, four pb5-VHH complexes formed following structures: Beginning of a crystal-
line formation of pb5-VHH53 (5.7 mg/ml) with 0.2 M calcium chloride dihydrate, 0.1 M tris 
pH 8, 20 % w/v PEG 6000.  Two probable crystals of pb5-VHH53 (5.7 mg/ml) with 0.2 M 
calcium chloride dihydrate, 0.1 M tris pH 8, 20 % w/v PEG 6000.  Few round crystals of 
pb5-VHH64 (2.3 mg/ml) with 0.2 M calcium chloride dihydrate 0.1 M tris, pH 8, 20 % w/v 
PEG 6000 and lastly a needle-like crystal of pb5-VHH81 (6.5 mg/ml) with 0.1 M citrate pH 
5, 20 % w/v PEG 6000. 
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Figure 17. A: Few round crystals of FhuA-pb5-VHH64 complex (6.9 mg/ml) B: FhuA-pb5-VHH53 
(6.7 mg/ml) forming a single crystal. C: Starting crystalline formation of pb5-VHH53 (5.7 
mg/ml. D: Two possible crystals of pb5-VHH53 (5.7 mg/ml). E: Some round crystals of 
pb5-VHH64 (2.3 mg/ml.  F: A needle-like crystal of pb5-VHH81 (6.5 mg/ml). 
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5 Conclusion 
Through the process of the elaboration of this project, the handling of the three different 
types of proteins: FhuA, pb5 and VHH antibodies was successful, concerning the per-
formed expression and purification by the means of using chromatographic methods. 
Even though small optimizing might be useful, the protocols used in the laboratory are 
suitable for all the three proteins. 
A major difficulty when handling the tail tip protein pb5 was encountered, due to its easy 
aggregation and resistance to the detergents. It would be of preference to perform a 
screening of the different environments possible for this protein, in order to find the most 
suitable buffer and salt concentration, providing the most optimal conditions. In fact, the 
testing of these different environments was started by employing a Differential Scanning 
Fluorimetry (DSF) and could be continued further. 
As for the crystallization, it has to be taken into account the fact that obtaining crystals 
with membrane protein complexes represents a major difficulty in the project. Despite of 
this challenge, some crystals of FhuA-pb5-VHH and pb5-VHH complexes were formed 
in the HTX laboratory, which is going to lead into X-ray crystallography measurement by 
the laboratory team.  
The present thesis project has provided more information about the expression and pu-
rification of the studied proteins, and despite the limited time, it allowed small optimization 
of the different methods. Overall, the thesis project was favorable towards the improve-
ment of various steps and provided extra information on the handling of the different 
proteins. 
Finally, the research project will be continued in the near future, with the purpose of 
obtaining optimal crystals of the complex capable of being used for X-ray crystallography. 
Consequently, the structure of the FhuA-pb5 complex could be solved and the phage’s 
infection process and interaction would be enlightened. This may have future applica-
tions in phage therapy, for bacteriophages to treat pathogenic bacterial infections, as 
bacteriophages are much more specific than antibiotics with a high therapeutic index. 
This means that phage therapy would be expected to cause fewer side effects. 
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